(Q89700420)

English

Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report

scientific article published on 11 March 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

B-cell non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

author name string

Wen-Ying Zhang

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Yao Wang

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Ye-Lei Guo

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Han-Ren Dai

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Qing-Ming Yang

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Ya-Jing Zhang

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Yan Zhang

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Mei-Xia Chen

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Chun-Meng Wang

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Kai-Chao Feng

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Su-Xia Li

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Yang Liu

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Feng-Xia Shi

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Can Luo

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Wei-Dong Han

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

publication date

11 March 2016

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

16002

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

copyright license

Creative Commons Attribution 4.0 International

11 March 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune surveillance of tumors

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive immunotherapy for cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Video podcast: Adoptive immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Managing cytokine release syndrome associated with novel T cell-engaging therapies.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

CD5- and CD23-positive splenic diffuse large B-cell lymphoma with very low CD20 expression

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

[Impact of chemotherapies on immunosuppression and discovery of new therapeutic targets]

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Organ-specific migration of mesenchymal stromal cells: Who, when, where and why?

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

PD-1 blockade induces responses by inhibiting adaptive immune resistance

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2016.2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29263894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29263894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SIGTRANS.2016.2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263894%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q89700420&oldid=1853306182"